Detalles de la búsqueda
1.
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma.
Leuk Lymphoma
; 54(12): 2606-12, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23488604
Resultados
1 -
1
de 1
1
Próxima >
>>